Patent 9975885 was granted and assigned to Purdue Research Foundation on May, 2018 by the United States Patent and Trademark Office.
This invention pertains to materials and methods for the treatment of patients with coronavirus infection and the control of zoonotic disease outbreaks using broad-spectrum non-covalent coronavirus protease inhibitors.